London
· Delayed Price · Currency is GBP · Price in GBXHUTCHMED (China) Statistics
Total Valuation
HUTCHMED (China) has a market cap or net worth of GBP 2.16 billion. The enterprise value is 1.61 billion.
| Market Cap | 2.16B |
| Enterprise Value | 1.61B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HUTCHMED (China) has 854.55 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Shares Outstanding | 854.55M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 27.74% |
| Float | 502.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.47 |
| PB Ratio | 3.69 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -48.35 |
| EV / Sales | 3.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.06 |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 11.78.
| Current Ratio | 2.81 |
| Quick Ratio | 2.66 |
| Debt / Equity | 11.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.36 |
| Interest Coverage | -159.16 |
Financial Efficiency
Return on equity (ROE) is -5.44% and return on invested capital (ROIC) is -8.98%.
| Return on Equity (ROE) | -5.44% |
| Return on Assets (ROA) | -5.90% |
| Return on Capital (ROIC) | -8.98% |
| Revenue Per Employee | 245,336 |
| Profits Per Employee | -16,858 |
| Employee Count | 1,988 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 13.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.95% |
| 50-Day Moving Average | 282.79 |
| 200-Day Moving Average | 273.81 |
| Relative Strength Index (RSI) | 35.30 |
| Average Volume (20 Days) | 95,329 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HUTCHMED (China) had revenue of GBP 483.31 million and -33.21 million in losses. Loss per share was -0.04.
| Revenue | 483.31M |
| Gross Profit | -37.55M |
| Operating Income | -95.59M |
| Pretax Income | -29.71M |
| Net Income | -33.21M |
| EBITDA | -87.16M |
| EBIT | -95.59M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 635.79 million in cash and 70.10 million in debt, giving a net cash position of 565.69 million or 0.66 per share.
| Cash & Cash Equivalents | 635.79M |
| Total Debt | 70.10M |
| Net Cash | 565.69M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 595.05M |
| Book Value Per Share | 0.69 |
| Working Capital | 534.09M |
Cash Flow
In the last 12 months, operating cash flow was -37.17 million and capital expenditures -14.53 million, giving a free cash flow of -51.70 million.
| Operating Cash Flow | -37.17M |
| Capital Expenditures | -14.53M |
| Free Cash Flow | -51.70M |
| FCF Per Share | -0.06 |
Margins
Gross margin is -7.77%, with operating and profit margins of -19.78% and -6.87%.
| Gross Margin | -7.77% |
| Operating Margin | -19.78% |
| Pretax Margin | -6.15% |
| Profit Margin | -6.87% |
| EBITDA Margin | -18.03% |
| EBIT Margin | -19.78% |
| FCF Margin | -10.70% |
Dividends & Yields
HUTCHMED (China) does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | -1.54% |
| FCF Yield | -2.39% |
Stock Splits
The last stock split was on May 30, 2019. It was a forward split with a ratio of 10.
| Last Split Date | May 30, 2019 |
| Split Type | Forward |
| Split Ratio | 10 |